TY  - JOUR
AU  - Garcia-de-Lucas, Maria Dolores
AU  - Miramontes-Gonzalez, Jose Pablo
AU  - Aviles-Bueno, Beatriz
AU  - Jimenez-Millan, Ana Isabel
AU  - Rivas-Ruiz, Francisco
AU  - Perez-Belmonte, Luis M
PY  - 2022
DO  - 10.3389/fendo.2022.995646
SN  - 1664-2392
UR  - http://hdl.handle.net/10668/20571
T2  - Frontiers in endocrinology
AB  - To investigate the use of once-weekly semaglutide in a real population of people with type 2 diabetes mellitus (T2DM) in three Spanish hospitals. An observational, retrospective and multicenter clinical study was designed that included 166...
LA  - en
PB  - Frontiers Research Foundation
KW  - HbA1c
KW  - T2DM
KW  - Body weight
KW  - Once-weekly semaglutide
KW  - Real-world use
KW  - Adult
KW  - Ambulatory Care Facilities
KW  - Body Weight
KW  - Diabetes Mellitus, Type 2
KW  - Glucagon-Like Peptides
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Retrospective Studies
KW  - Spain
TI  - Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain.
TY  - research article
VL  - 13
ER  -